Introvigne, M.L.; Beardsley, T.J.; Fernando, M.C.; Leonard, D.A.; Wallar, B.J.; Rudin, S.D.; Taracila, M.A.; Rather, P.N.; Colquhoun, J.M.; Song, S.;
et al. Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii. Antibiotics 2023, 12, 644.
https://doi.org/10.3390/antibiotics12040644
AMA Style
Introvigne ML, Beardsley TJ, Fernando MC, Leonard DA, Wallar BJ, Rudin SD, Taracila MA, Rather PN, Colquhoun JM, Song S,
et al. Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii. Antibiotics. 2023; 12(4):644.
https://doi.org/10.3390/antibiotics12040644
Chicago/Turabian Style
Introvigne, Maria Luisa, Trevor J. Beardsley, Micah C. Fernando, David A. Leonard, Bradley J. Wallar, Susan D. Rudin, Magdalena A. Taracila, Philip N. Rather, Jennifer M. Colquhoun, Shaina Song,
and et al. 2023. "Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii" Antibiotics 12, no. 4: 644.
https://doi.org/10.3390/antibiotics12040644
APA Style
Introvigne, M. L., Beardsley, T. J., Fernando, M. C., Leonard, D. A., Wallar, B. J., Rudin, S. D., Taracila, M. A., Rather, P. N., Colquhoun, J. M., Song, S., Fini, F., Hujer, K. M., Hujer, A. M., Prati, F., Powers, R. A., Bonomo, R. A., & Caselli, E.
(2023). Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii. Antibiotics, 12(4), 644.
https://doi.org/10.3390/antibiotics12040644
